Insider Transactions in Q1 2022 at Xenon Pharmaceuticals Inc. (XENE)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2022
|
Simon N. Pimstone |
SELL
Open market or private sale
|
Direct |
14,551
-1.27%
|
$363,775
$25.96 P/Share
|
|
Mar 07
2022
|
James R. Empfield EVP, Drug Discovery |
SELL
Open market or private sale
|
Direct |
32,853
-39.93%
|
$985,590
$30.58 P/Share
|
|
Mar 07
2022
|
James R. Empfield EVP, Drug Discovery |
SELL
Payment of exercise price or tax liability
|
Direct |
9,647
-11.42%
|
$289,410
$30.23 P/Share
|
|
Mar 07
2022
|
James R. Empfield EVP, Drug Discovery |
BUY
Exercise of conversion of derivative security
|
Direct |
42,500
+30.12%
|
$297,500
$7.58 P/Share
|
|
Mar 07
2022
|
Simon N. Pimstone |
SELL
Open market or private sale
|
Direct |
31,086
-2.06%
|
$932,580
$30.51 P/Share
|
|
Mar 07
2022
|
Simon N. Pimstone |
SELL
Payment of exercise price or tax liability
|
Direct |
1,990
-0.86%
|
$59,700
$30.23 P/Share
|
|
Mar 07
2022
|
Simon N. Pimstone |
BUY
Exercise of conversion of derivative security
|
Direct |
20,576
+8.19%
|
$61,728
$3.67 P/Share
|
|
Mar 04
2022
|
James R. Empfield EVP, Drug Discovery |
SELL
Open market or private sale
|
Direct |
18,315
-64.68%
|
$549,450
$30.79 P/Share
|
|
Mar 04
2022
|
James R. Empfield EVP, Drug Discovery |
SELL
Payment of exercise price or tax liability
|
Direct |
6,685
-19.1%
|
$207,235
$31.42 P/Share
|
|
Mar 04
2022
|
James R. Empfield EVP, Drug Discovery |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+41.67%
|
$200,000
$8.4 P/Share
|
|
Mar 04
2022
|
Sherrington Robin EVP, Strategy & Innovation |
SELL
Open market or private sale
|
Direct |
21,710
-18.4%
|
$651,300
$30.5 P/Share
|
|
Mar 04
2022
|
Sherrington Robin EVP, Strategy & Innovation |
BUY
Exercise of conversion of derivative security
|
Direct |
7,406
+8.62%
|
$22,218
$3.67 P/Share
|
|
Mar 04
2022
|
Sherrington Robin EVP, Strategy & Innovation |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-2.08%
|
$21,576
$31.42 P/Share
|
|
Mar 04
2022
|
Simon N. Pimstone |
SELL
Open market or private sale
|
Direct |
9,325
-2.15%
|
$279,750
$30.61 P/Share
|
|
Mar 04
2022
|
Simon N. Pimstone |
SELL
Payment of exercise price or tax liability
|
Direct |
963
-0.44%
|
$29,853
$31.42 P/Share
|
|
Mar 04
2022
|
Simon N. Pimstone |
BUY
Exercise of conversion of derivative security
|
Direct |
10,288
+4.46%
|
$30,864
$3.67 P/Share
|
|
Jan 21
2022
|
Christopher John Kenney Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
700
+50.0%
|
$19,600
$28.81 P/Share
|